Advertisement

Related Videos

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

Varsha Gandhi, PhD, on Ibrutinib

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Peter Clark, MA, MD, FRCP: A Payer Perspective

Advertisement

Advertisement




Feb
05
Today In Oncology
Can R-CHOP–Like Therapy Effectively Treat Late-Relapse DLBCL
Bicistronic CAR T-Cell Therapy Demonstrates Clinical Activity in Relapsed or Refractory B-Cell ALL
Predicting Response to KRAS G12C Inhibitors in NSCLC
Rising Advanced Prostate Cancer Rates in California Follow Changes to Recommendations
Trastuzumab Pertuzumab Plus Eribulin or Taxane in Locally Advanced or Metastatic Breast Cancer
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo